HIV-positive people not on antiretrovirals are prone to inflammation-related bone loss
HIV-positive young women have adequate response to human papillomavirus vaccine
Only a fifth of pregnancies among women living with HIV in the US are planned
Predicting response to acute hepatitis C treatment in HIV/HCV co-infected people
Young people (15 to 24 years) especially likely to drop out of HIV care
Eviplera works well regardless of viral load or CD4 count, may improve lipid levels
Unravelling the mystery of the vaccine trials
HIV monitoring every six months is adequate for people on ART with stable viral suppression
